New Wave Biotech

New Wave Biotech builds Bioprocess Foresight, an AI-powered downstream process (DSP) optimisation platform designed for biomanufacturers seeking to accelerate R&D, reduce costs, and improve sustainability. By combining hybrid AI modelling — integrating mechanistic science with machine learning — with fully integrated techno-economic analysis (TEA) and life cycle assessment (LCA), the platform enables R&D and operations teams to simulate thousands of process scenarios in silico, run more targeted experiments, and reach the right process faster. The platform learns from every experiment and transfers knowledge across products, becoming progressively smarter with use.

New Wave Biotech serves R&D teams, sustainability directors, and operations leaders at food ingredients, industrial biotech, and pharmaceutical companies across the UK, Europe, Asia, and North America. Trusted customers and collaborators include the Centre for Process Innovation (CPI), Multus, and Liven, with the platform demonstrating validated results including an 8.6X yield improvement, 55% unit cost reduction, and 92% fewer experiments compared to traditional Design of Experiments (DoE) approaches.

Core Platform Modules

• AI-Powered Simulations: Virtual testing tailored to your specific process and data, enabling users to run scenarios ranging from high-level product target changes to detailed unit operation parameters. The system continuously improves as new data is added, leveraging historical data to enhance predictions and power future R&D.
• DSP Optimisation: Automatically tests thousands of downstream processes in silico to identify the highest-potential options, focusing experimentation on the most promising routes and continuously improving as experimental results are fed back into the model. Delivers cheaper and faster R&D, boosted production, lower unit costs, and a growing competitive advantage.
• Dynamic Techno-Economic Analysis (TEA): A living TEA that evolves alongside the process, aligning technical and commercial strategies. Includes analytics tools to identify R&D hotspots and dynamically models scenarios to determine the best path to scale, helping teams foresee the impact of decisions and focus resources on what matters most.
• Automated Life Cycle Assessment (LCA): Provides dynamic environmental impact simulations with no LCA expertise or external tools required. Covers key environmental indicators including carbon emissions, energy, water, and waste from the first iteration. Datasets and methods are specifically catered towards biotechnology, giving teams a clear breakdown of environmental impact instantly.

Validated Performance and Key Results

• Achieved a 6.5% prediction error from a single calibration run, validated at pilot scale (350–700L) in collaboration with the Centre for Process Innovation (CPI), the UK's national innovation centre for process industries — delivering 1.4–4X greater accuracy than the industry average.
• Ongoing collaboration with CPI to optimise solvent and non-solvent lipid extraction processes.
• Delivered an 8.6X yield improvement and 55% unit cost reduction for Multus through four cycles of filtration optimisation, each simulating over 10,000 scenarios and incorporating experimental feedback — achieving 92% fewer experiments than traditional DoE methods.
• Simulated thousands of production routes for plant-based collagen for Liven, benchmarking techno-economic performance and environmental impact across sourcing, transport, and production locations, enabling side-by-side comparison of sustainability and cost.

Who New Wave Biotech Serves

• Biotech developers: Optimise bioprocesses to scale more quickly and cost-effectively, and leverage historical data to power ongoing R&D.
• Equipment companies: Demonstrate the impact of their technology to customers and accelerate application development.
• Food ingredients, industrial biotech, and pharmaceutical companies seeking to make sustainable processes commercially viable and viable processes more sustainable.

Team and Background

• Founded and backed by a team with deep expertise spanning chemical engineering, bioprocess science, machine learning, life cycle assessment, and software development.
• Operates across the UK, Europe, Asia, and North America.
• Supported by external backers and featured in industry media, with active hiring for passionate and talented individuals across disciplines.

New Wave Biotech's Bioprocess Foresight platform is purpose-built to help biomanufacturers get their biotechnology to market faster, cheaper, and greener — combining the predictive power of AI with the commercial and environmental context needed to make confident, data-driven decisions at every stage of process development.